Cargando…

Liver Resection for Hepatocellular Carcinoma in Patients with Renal Dysfunction

BACKGROUND: The aim of this study was to evaluate the feasibility of liver resection in hepatocellular carcinoma (HCC) patients with preoperative renal dysfunction (RD). METHODS: Data from 735 patients undergoing primary liver resection for HCC between 2002 and 2014 were analyzed. Short- and long-te...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirata, Chikara, Hasegawa, Kiyoshi, Kokudo, Takashi, Yamashita, Suguru, Yamamoto, Satoshi, Arita, Junichi, Akamatsu, Nobuhisa, Kaneko, Junichi, Sakamoto, Yoshihiro, Kokudo, Norihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101999/
https://www.ncbi.nlm.nih.gov/pubmed/29947980
http://dx.doi.org/10.1007/s00268-018-4698-3
_version_ 1783511733460008960
author Shirata, Chikara
Hasegawa, Kiyoshi
Kokudo, Takashi
Yamashita, Suguru
Yamamoto, Satoshi
Arita, Junichi
Akamatsu, Nobuhisa
Kaneko, Junichi
Sakamoto, Yoshihiro
Kokudo, Norihiro
author_facet Shirata, Chikara
Hasegawa, Kiyoshi
Kokudo, Takashi
Yamashita, Suguru
Yamamoto, Satoshi
Arita, Junichi
Akamatsu, Nobuhisa
Kaneko, Junichi
Sakamoto, Yoshihiro
Kokudo, Norihiro
author_sort Shirata, Chikara
collection PubMed
description BACKGROUND: The aim of this study was to evaluate the feasibility of liver resection in hepatocellular carcinoma (HCC) patients with preoperative renal dysfunction (RD). METHODS: Data from 735 patients undergoing primary liver resection for HCC between 2002 and 2014 were analyzed. Short- and long-term outcomes were compared between the RD group, defined by a preoperative estimated glomerular filtration rate of <45 mL/min/1.73 m(2), and the non-RD group. RESULTS: Sixty-two patients had RD. The incidence of postoperative pleural effusion (24 vs. 11%; P = 0.007) and major complications (Clavien–Dindo III–V; 31 vs. 15%; P = 0.003) were significantly higher in RD patients. In RD patients with Child-Pugh A, 90-day mortality rate (1.9%) and median survival time (6.11 years) were comparable to that of non-RD patients. In contrast, RD patients with Child-Pugh B had a very high 90-day mortality rate (22.2%), and a significant shorter median survival time compared to non-RD patients (1.19 vs. 4.84 years; P = 0.001). CONCLUSIONS: Liver resection for Child-Pugh A patients with RD is safe and has comparable oncological outcomes compared to non-RD patients. However, selection of liver resection candidates from Child-Pugh B patients with RD should be stricter. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00268-018-4698-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7101999
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-71019992020-03-31 Liver Resection for Hepatocellular Carcinoma in Patients with Renal Dysfunction Shirata, Chikara Hasegawa, Kiyoshi Kokudo, Takashi Yamashita, Suguru Yamamoto, Satoshi Arita, Junichi Akamatsu, Nobuhisa Kaneko, Junichi Sakamoto, Yoshihiro Kokudo, Norihiro World J Surg Original Scientific Report BACKGROUND: The aim of this study was to evaluate the feasibility of liver resection in hepatocellular carcinoma (HCC) patients with preoperative renal dysfunction (RD). METHODS: Data from 735 patients undergoing primary liver resection for HCC between 2002 and 2014 were analyzed. Short- and long-term outcomes were compared between the RD group, defined by a preoperative estimated glomerular filtration rate of <45 mL/min/1.73 m(2), and the non-RD group. RESULTS: Sixty-two patients had RD. The incidence of postoperative pleural effusion (24 vs. 11%; P = 0.007) and major complications (Clavien–Dindo III–V; 31 vs. 15%; P = 0.003) were significantly higher in RD patients. In RD patients with Child-Pugh A, 90-day mortality rate (1.9%) and median survival time (6.11 years) were comparable to that of non-RD patients. In contrast, RD patients with Child-Pugh B had a very high 90-day mortality rate (22.2%), and a significant shorter median survival time compared to non-RD patients (1.19 vs. 4.84 years; P = 0.001). CONCLUSIONS: Liver resection for Child-Pugh A patients with RD is safe and has comparable oncological outcomes compared to non-RD patients. However, selection of liver resection candidates from Child-Pugh B patients with RD should be stricter. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00268-018-4698-3) contains supplementary material, which is available to authorized users. Springer International Publishing 2018-06-08 2018 /pmc/articles/PMC7101999/ /pubmed/29947980 http://dx.doi.org/10.1007/s00268-018-4698-3 Text en © Société Internationale de Chirurgie 2018 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Scientific Report
Shirata, Chikara
Hasegawa, Kiyoshi
Kokudo, Takashi
Yamashita, Suguru
Yamamoto, Satoshi
Arita, Junichi
Akamatsu, Nobuhisa
Kaneko, Junichi
Sakamoto, Yoshihiro
Kokudo, Norihiro
Liver Resection for Hepatocellular Carcinoma in Patients with Renal Dysfunction
title Liver Resection for Hepatocellular Carcinoma in Patients with Renal Dysfunction
title_full Liver Resection for Hepatocellular Carcinoma in Patients with Renal Dysfunction
title_fullStr Liver Resection for Hepatocellular Carcinoma in Patients with Renal Dysfunction
title_full_unstemmed Liver Resection for Hepatocellular Carcinoma in Patients with Renal Dysfunction
title_short Liver Resection for Hepatocellular Carcinoma in Patients with Renal Dysfunction
title_sort liver resection for hepatocellular carcinoma in patients with renal dysfunction
topic Original Scientific Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101999/
https://www.ncbi.nlm.nih.gov/pubmed/29947980
http://dx.doi.org/10.1007/s00268-018-4698-3
work_keys_str_mv AT shiratachikara liverresectionforhepatocellularcarcinomainpatientswithrenaldysfunction
AT hasegawakiyoshi liverresectionforhepatocellularcarcinomainpatientswithrenaldysfunction
AT kokudotakashi liverresectionforhepatocellularcarcinomainpatientswithrenaldysfunction
AT yamashitasuguru liverresectionforhepatocellularcarcinomainpatientswithrenaldysfunction
AT yamamotosatoshi liverresectionforhepatocellularcarcinomainpatientswithrenaldysfunction
AT aritajunichi liverresectionforhepatocellularcarcinomainpatientswithrenaldysfunction
AT akamatsunobuhisa liverresectionforhepatocellularcarcinomainpatientswithrenaldysfunction
AT kanekojunichi liverresectionforhepatocellularcarcinomainpatientswithrenaldysfunction
AT sakamotoyoshihiro liverresectionforhepatocellularcarcinomainpatientswithrenaldysfunction
AT kokudonorihiro liverresectionforhepatocellularcarcinomainpatientswithrenaldysfunction